Dr Gilberto Lopes is an Associated Professor of Clinical Medicine and Associate Director at the Sylvester Comprehensive Cancer Center at the University of Miami, Florida, USA.
He specializes in lung cancer and his research interests include drug development and global oncology. He is Editor-in-Chief of the Journal of Clinical Oncology: Global Oncology and was the presenting author of the phase 3 KEYNOTE-042 trial at the Plenary Session of the ASCO Annual Meeting 2018.